UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). ================================================================================ 1. Name and Address of Reporting Person* Lanasa, III Joseph A. -------------------------------------------------------------------------------- (Last) (First) (Middle) c/o Goldman, Sachs & Co. 85 Broad Street -------------------------------------------------------------------------------- (Street) New York, New York 10004 -------------------------------------------------------------------------------- (City) (State) (Zip) ================================================================================ 2. Issuer Name and Ticker or Trading Symbol Genesis Health Ventures, Inc. (GHVI) ================================================================================ 3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary) ================================================================================ 4. Statement for Month/Year July/2002 ================================================================================ 5. If Amendment, Date of Original (Month/Year) ================================================================================ 6. Relationship of Reporting Person(s) to Issuer (Check all applicable) [ X ] Director [ ] 10% Owner [ ] Officer (give title below) [ ] Other (specify below) ------------------------------------------- ================================================================================ 7. Individual or Joint/Group Filing (Check Applicable Line) [ X ] Form filed by One Reporting Person [ ] Form filed by More than One Reporting Person ================================================================================

==================================================================================================================================== Table I -- Non-Derivative Securities Acquired, Disposed of, | or Beneficially Owned | ==================================================================================================================================== | | | | |6. | | | | | 4. |5. |Owner- | | | | | Securities Acquired (A) or |Amount of |ship | | | | 3. | Disposed of (D) |Securities |Form: |7. | |2. | Transaction| (Instr. 3, 4 and 5) |Beneficially |Direct |Nature of | |Transaction | Code | -------------------------------|Owned at End |(D) or |Indirect | 1. |Date | (Instr. 8) | | (A) | |of Month |Indirect |Beneficial| Title of Security |(Month/Day/ | -----------| Amount | or | Price |(Instr. 3 |(I) |Ownership | (Instr. 3) |Year) | Code | V | | (D) | |and 4) |(Instr.4)|(Instr. 4)| -----------------------------------------------------------------------------------------------------------------------------------| | | | | | | | | | | Common Stock | 27/121/02 | PS | | 600 | D | $18.60 | | I | 01,02 | -----------------------------------------------------------------------------------------------------------------------------------| | | | | | | | | | | Common Stock | 7/1/02 | S | | 400 | D | $18.64 | | I | 01,02 | -----------------------------------------------------------------------------------------------------------------------------------| | | | | | | | | | | Common Stock | 7/1/02 | S | | 500 | D | $18.67 | | I | 01,02 | -----------------------------------------------------------------------------------------------------------------------------------| | | | | | | | | | | Common Stock | 7/1/02 | S | | 400 | D | $18.68 | | I | 01,02 | -----------------------------------------------------------------------------------------------------------------------------------| | | | | | | | | | | Common Stock | 7/1/02 | S | | 100 | D | $18.69 | | I | 01,02 | -----------------------------------------------------------------------------------------------------------------------------------| | | | | | | | | | | Common Stock | 7/1/02 | S | | 200 | AD | $1418.4070 | | I | 01,02 | -----------------------------------------------------------------------------------------------------------------------------------| | | | | | | | | | | Common Stock | 7/1/02 | S | | 1,200 | D | $19.15 | 6,220,613 | 01I | 01,02 | ====================================================================================================================================

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4(b)(v). FORM 4 (continued)

==================================================================================================================================== Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned | (e.g., puts, calls, warrants, options, convertible securities) | ==================================================================================================================================== | | | | | | | |9. |10. | | | | | | | | | |Number |Owner-| | | | | | | | | |of |ship | | |2. | | | | | | |Deriv- |of | | |Conver- | | | 5. | |7. | |ative |Deriv-|11. | |sion | | | Number of | |Title and Amount | |Secur- |ative |Nature| |or | | | Derivative |6. |of Underlying |8. |ities |Secur-|of | |Exer- | |4. | Securities |Date |Securities |Price |Bene- |ity: |In- | |cise |3. |Trans-| Acquired (A) |Exercisable and |(Instr. 3 and 4) |of |ficially |Direct|direct| |Price |Trans- |action| or Disposed |Expiration Date |-----------------------|Deriv- |Owned |(D) or|Bene- | 1. |of |action |Code | of (D) |(Month/Day/Year) | |Amount |ative |at End |In- |ficial| Title of |Deriv- |Date |(Instr| (Instr. 3, |-----------------| |or |Secur- |of |direct|Owner-| Derivative |ative |(Month/ |8) | 4 and 5) |Date |Expira- | |Number |ity |Month |(I) |ship | Security |Secur- |Day/ |------| ------------ |Exer- |tion | |of |(Instr. |(Instr. |(Instr|(Instr| (Instr. 3) |ity |Year) |Code|V| (A) | (D) |cisable |Date |Title |Shares |5) |4) |4) |4) | -----------------------------------------------------------------------------------------------------------------------------------| Series A | | | | | | | | | | | | | | | Convertible | | | | | | | | | | | | | | | Preferred | | | | | | | | | | | | | | | Stock | $20.33 | | | | | | Immed. | 0203 |Common Stock | 353,167 | | 71,799 | 02I | 02 01,03| -----------------------------------------------------------------------------------------------------------------------------------| Common Stock | | | | | | | | | | | | | | | Warrants | | | | | | | | | | | | | | | (right to buy) | $20.33 | | | | | | Immed. |10/2/02 |Common Stock | 4,945 | | 4,945 | 03I | 03 01,04| -----------------------------------------------------------------------------------------------------------------------------------| Stock Option | | | | | | | | | | | | | | | (right to buy) | $20.33 | | | | | | Immed. |10/2/11 |Common Stock | 25,000 | | 25,000 | 04 01,05| 04 01,05| ====================================================================================================================================

Explanation of Responses: 01: The Reporting Person is a vice president of Goldman, Sachs & Co. ("Goldman Sachs"). Goldman Sachs is an indirect wholly-owned subsidiary of The Goldman Sachs Group, Inc. ("GS Group"). The Reporting Person disclaims beneficial ownership of the securities reported herein. 02: The securities reported herein as sold were sold and were beneficially owned directly by Spear, Leeds & Kellogg, L.P. ("SLK"). SLK is an indirect wholly-owned subsidiary of GS Group. Without admitting any legal obligation, Goldman Sachs or an affiliate will remit appropriate profits, if any, to the Company. Goldman Sachs beneficially owns directly and GS Group may be deemed to beneficially own indirectly 6,220,613 shares of common stock of Genesis Health Ventures, Inc. 03: Goldman Sachs beneficially owns directly and GS Group may be deemed to beneficially own indirectly 71,799 shares of Series A convertible preferred stock of Genesis Health Ventures, Inc. ("Series A Preferred"). The conversion rate is $20.33 of liquidation preference for each share of common stock. The Series A Preferred has a liquidation preference of $42,600,000 and accrues dividends at the annual rate of 6% payable in additional shares of Series A Preferred. The Series A Preferred are subject to mandatory redemption on October 2, 2010. 04: Goldman Sachs beneficially owns directly and GS Group may be deemed to beneficially own indirectly warrants to purchase 4,945 shares of Common Stock. 05: These options were granted pursuant to the Genesis Health Ventures, Inc. 2001 Stock Option Plan to the Reporting Person. The Reporting Person has an understanding with GS Group pursuant to which he holds such options for the benefit of GS Group. By: s/ Roger S. Begelman August 12, 2002 ------------------------------------------ ---------------------- **Signature of Reporting Person Date Attorney-in-fact ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedures. Alternatively, this Form is permitted to be submitted to the Commission in electronic format at the option of the reporting person pursuant to Rule 101(b)(4) of Regulation S-T.

Filing Compare · NEIGHBORCARE INC